BRIEF

on MeVis Medical Solutions AG (isin : DE000A0LBFE4)

MeVis Medical Solutions AG Announces Fiscal Results and Forecast

Stock price chart of MeVis Medical Solutions AG (EBR:M3V) showing fluctuations.

MeVis Medical Solutions AG, a prominent medical imaging software provider, reported its financial results for the fiscal year 2023/2024, ending September 30, 2024. The company achieved revenues of €17.0 million, slightly down from €17.3 million in the previous year. The decline in license revenues, attributed to reduced demand from clients Philips and Canon, and lower maintenance revenues from Hologic contributed to this decrease.

Earnings before interest and taxes (EBIT) declined to €3.5 million, reflecting a 21% margin due to decreased revenues and higher staff costs. Nonetheless, profit after tax stood at €4.6 million, benefiting from minimal income taxes. For the upcoming fiscal year 2024/2025, MeVis projects revenues to rise marginally to €17.5 million and EBIT to improve, assuming stable currency exchange rates.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MeVis Medical Solutions AG news